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Abstract
Adenosine 39, 59-cyclic monophosphate (cAMP) and guanosine 39, 59-cyclic monophosphate (cGMP) are well-studied second
messengers that transmit extracellular signals into mammalian cells, with conserved functions in various other species such
as Caenorhabditis elegans (C. elegans). cAMP is generated by adenylyl cyclases, and cGMP is generated by guanylyl cyclases,
respectively. Studies using C. elegans have revealed additional roles for cGMP signaling in lifespan extension. For example,
mutants lacking the function of a specific receptor-bound guanylyl cyclase, DAF-11, have an increased life expectancy. While
the daf-11 phenotype has been attributed to reductions in intracellular cGMP concentrations, the actual content of cyclic
nucleotides has not been biochemically determined in this system. Similar assumptions were made in studies using
phosphodiesterase loss-of-function mutants or using adenylyl cyclase overexpressing mutants. In the present study, cyclic
nucleotide regulation in C. elegans was studied by establishing a special nematode protocol for the simultaneous detection
and quantitation of cyclic nucleotides. We also examined the influence of reactive oxygen species (ROS) on cyclic nucleotide
metabolism and lifespan in C. elegans using highly specific HPLC-coupled tandem mass-spectrometry and behavioral assays.
Here, we show that the relation between cGMP and survival is more complex than previously appreciated.
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Introduction
The first description of guanosine 39, 59-cyclic monophosphate
(cGMP) as a biological substance can be dated back to 1963 [1].
cGMP is now a well-established second messenger, like the earlier
identified adenosine 39, 59-cyclic monophosphate (cAMP) [2,3].
These cyclic nucleotides (cNMPs) are generated by the ATP- and
GTP-converting adenylyl- and guanylyl cyclase, respectively
[1,2,3,4,5]. cAMP and cGMP transmit extracellular signals into
mammalian cells, with conserved functions in various other species
such as Caenorhabditis elegans. In mammals, two classes of cGMP-
forming enzymes have been identified: the soluble, nitric oxide
(NO)-dependent guanylyl cyclase (sGC) and the particulate
(membrane-bound) guanylyl cyclases (pGC) that are activated by
natriuretic peptides [4,5,6,7,8] (reviewed in [8]). cGMP has an
impact on various physiological processes such as smooth muscle
relaxation, platelet aggregation and phototransduction. Not
surprisingly, the cGMP signaling cascade has become an
important pharmacological target, with successful regimens
developed for the therapy of heart failure, (pulmonary) arterial
hypertension and erectile dysfunction [9,10].
C. elegans was first established as laboratory model organism by
Sydney Brenner in 1974 [11]. It has become a favored model
organism in genetic studies due, in part, to the completion of its
genome sequence in 1998. Forty-two percent of the approximately
20,000 predicted C. elegans genes have homology to human genes
[12], including those encoding guanylyl cyclases. The genome of
C. elegans harbors 32 genes with similarity to guanylyl cyclases.
These include 25 membrane-bound, receptor-like guanylyl
cyclases and 7 cytosolic guanylyl cyclases (gcy-31–gcy-37) [13].
Two of the receptor-bound guanylyl cyclase genes, daf-11 and odr-
1, are expressed in olfactory and pheromone-sensing neurons and
act downstream of G-protein-coupled receptors. daf-11 is ex-
pressed in the ciliated ASI, ASJ, AWC, AWB, ASK neurons where
it is involved in olfactory and pheromone sensing and behavior
[14,15]. daf-11 plays a non-autonomous role in chemotaxis in
ciliated ASE neurons [14], and daf-11 regulates dauer-formation
and recovery.
Recent studies have revealed roles for daf-11 in C. elegans aging
and oxidative stress response pathways, leading to the conclusion
that cGMP signaling in C. elegans is interconnected with the
insulin/IGF-1/DAF-16 signaling pathway implicated in longevity
and stress resistance [16,17]. daf-11 mutants display enhanced
longevity that is dependent upon DAF-16/FOXO, a phenotype
that is similar to that observed in gpa-3 mutants with defects in G-
protein signaling in sensory neurons [16]. Several lines of evidence
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implicate altered cGMP pools in these GPA-3-related biological
functions: a) Constitutively activated gpa-3 mutants display an
increased tolerance to oxidants and an increased lifespan. b) daf-11
mutants defective in guanylyl cyclase display similar phenotypes
[16]. c) activation of the G-protein GPA-3 leads to an increase in
pde-1 and pde-5 mRNA levels [16]. As these genes encode
phosphodiesterase enzymes that degrade cNMPs, the cGMP pool
can be predicted to decrease as a result [16]. d) pde-1 and pde-
5 mRNA levels also increase when animals are exposed to cGMP;
similarly, transcriptional upregulation for these pde genes is also
observed when daf-11 mutants are exposed to cGMP [16]. e) daf-11
mutants exposed to dauer-inducing environmental conditions
display suppressed DAF-28/insulin levels, a finding which
provides an interesting link between cGMP production and the
insulin-related longevity and stress-response pathway [17].
Until now, it has not been shown biochemically that the daf-11
loss of function mutant indeed contains less cGMP than wild-type
animals. Moreover, C. elegans studies using phosphodiesterase loss-
of-function mutants in phototransduction experiments [18] or
adenylyl cyclase-overexpressing mutants in axon regeneration
experiments [19] also assumed higher levels of cNMPs. While it
may seem logical to assume that removal of one of the thirty-two
guanylyl cyclase enzymes from C. elegans might result in lower
intracellular levels of cGMP, studies from mammalian cardiac
tissue highlight the complexity of cNMP metabolism. The
intracellular concentrations of a given cNMP is a reflection of
the balance between its synthesis its degradation, coordinated
cross-talk between the cAMP and cGMP metabolic pathways [20],
and of allosteric regulation of enzyme function [21]. From the
studies in mammalian cells, we can anticipate that the six different
cAMP and cGMP phosphodiesterases in C. elegans are likely to be
allosterically regulated by cGMP and cAMP, respectively, and
subject to competitive inhibition as well. Thus, removal of the
catalytic enzyme may produce unanticipated outcomes in cNMP
concentrations. For example, it is feasible that a reduced level of
cGMP synthesis might lead to an increase in intracellular cAMP,
due to lack of allosteric inhibition by the corresponding
phosphodiesterase. In such a situation, cAMP might unexpectedly
be the effector molecule mediating biological functions. The
relatively simpler C. elegans genetics system affords particular
advantages for the analysis of such a complicated array of
regulatory connections. However, even though C. elegans has fewer
tissues and fewer gene splice variants than mammalian systems,
there are inherent complexities in an organism with thirty-two
guanylyl cyclases, four adenylyl cyclases, and six phosphodiester-
ase genes that are incompletely characterized biochemically. In the
present study, we established a highly specific HPLC-coupled
tandem mass-spectrometry method for the simultaneous detection
and quantitation of cAMP and cGMP in C. elegans. We used the
nematode as a model organism to examine the influence of
reactive oxygen species (ROS) on cNMP metabolism and lifespan.
The assays were directed towards a better understanding of the
roles of the guanylyl cyclase daf-11, cGMP phosphodiesterase, and
cGMP-dependent protein kinase within the oxidative stress
response of the nematode.
Materials and Methods
Materials
cGMP and cAMP were supplied by Biolog (Bremen, Germany)
in a purity of .99%. 29-Deoxy-5-fluorouridine (FUDR), forskolin
(FSK) and peptone were purchased from Sigma-Aldrich (Seelze,
Germany). Ammonium acetate was purchased from Fluka (Buchs,
Switzerland). Magnesium sulfate, di-potassium hydrogen phos-
phate, potassium di-hydrogen phosphate, di-sodium hydrogen
phosphate, sodium di-hydrogen phosphate, calcium chloride,
sodium chloride, sodium ammonium mono hydrogen phosphate,
H2O2 30% (v/v) and cholesterol were obtained from Merck
(Darmstadt, Germany). Sodium hypochlorite (NaOCl) 12% (v/v)
was purchased from Hedinger (Stuttgart, Germany). HPLC grade
acetonitrile, methanol and water were supplied by Baker
(Deventer, The Netherlands) and acetic acid was purchased from
Riedel de Häen (Seelze, Germany). RotiH Quant Bradford protein
quantitation reagent, ethanol and sodium hydroxide were supplied
by Roth (Karlsruhe, Germany). Taq Man probes and Taq Man
Gene Expression Mastermix were purchased from Applied
Biosystems (Carlsbad, CA, USA). 5x Real Time buffer was
purchased from Fermentas (St. Leon-Rot, Germany). Bactoagar
and LB Medium DifcoTM Luria Bertani Broth Miller were
supplied by Beckton Dickinson (Franklin Lakes, NJ, USA).
Tenofovir was obtained from National Institute of Health AIDS
Research and Reference Program, Division AIDS (Bethesda, MD,
USA).
Strains
The C. elegans strains used in this study were N2 Bristol (wild-
type), KG522 (acy-1 (md1756)III), KG744 (pde-4(ce268)II), DR47
(daf-11(m47)V), MT1074(egl-4/pkg-1(n479)IV) and TQ1828
(pde-1(nj57), pde-5(nj49) I, pde-3(nj59) II, pde-2(tm3098)III)
(Table S1) and were, as well as the food strain E. coli OP50,
provided by the Caenorhabditis elegans Genetics Center which is
funded by NIH Office of Research Infrastructure Programs (P40
OD010440) (University of Minnesota, MN, USA www.cbs.umn.
edu). For Table S1 we provide a supplementary reference list for
characterization of C. elegans strains. Maintenance of C. elegans
was performed as described [22].
Lifespan Analysis
Lifespan assays were performed at 22uC on normal growth
medium plates supplemented with 0.05 mg/ml FUDR (5-
fluorodeoxyuracil). FUDR prevented progeny overgrowth and
thus mixed generations. Synchronized populations were obtained
by picking L1 larvae and transferred to the FUDR plates on their
first day of adulthood (30–40 per plate, 3 plates each assay). The
number of worms was counted every 1–2 days until death. Worms
were counted dead when they did not respond to gentle prodding
at head and tail and no pharyngeal pumping could be observed.
Animals that crawled off the plate were excluded at the time of the
event, which allowed those worms to be incorporated in the data
set until the censor date and no loss of data occurred. Lifespan
counting was performed with a Nikon SMZ745T binocular
microscope (Nikon Europe, Düsseldorf, Germany).
Stress Response Assay in the Presence of 10 mM H2O2
Stress resistance assays were performed at 22uC in a 96-well
plate using each time freshly prepared 10 mM H2O2 as oxidative
agent, as established by Wang et al. 2006 [23]. Additional dose-
finding assays with C. elegans wild-type were performed (Figure S5)
in order to identify the suitable concentration for a time-
dependent stress assay setting. Synchronized populations were
obtained by picking L1 larvae and transfer to a 1.5 ml Eppendorf
tube containing 300 ml of M9 buffer. For one assay, about 30–40
worms were carefully distributed into the wells of the 96-well plate
(6–10 worms/well) containing 50 ml of 10 mM H2O2. Animals
were tapped every 15–30 min and scored as dead when they did
not respond to the prodding with a platinum pick. Animals whose
cuticle bursted directly after placing them in 10 mM H202 due to
physical stress of moving them, were excluded from the analysis by
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the Kaplan-Meier-methodology. There was no evidence for strain-
specific cuticle disruptions induced by H2O2. Lifespan counting
was performed under a Nikon SMZ745T binocular microscope
(Nikon Europe, Düsseldorf, Germany).
Forskolin Incubation
Five hundred to 1000 synchronized adult (72 h old) wild-type
hermaphrodites were washed with 1 ml M9 buffer into a 1.5 ml
Eppendorf tube. When the animals were settled down in the tube,
the buffer was aspirated and a mixture of E. coli OP50 in M9 buffer
and forskolin, a direct activator of adenlylyl cyclases [24], with a
final concentration of 50 mM was added [19]. Higher concentra-
tions of forskolin had no effect on cNMP concentrations of C.
elegans. The cause may have been the precipitation of forskolin in
higer concentrations due to the poor solubility in water/DMSO
(solubility of forskolin 5 mg/ml 100% DMSO). The bacteria were
needed for a better ingestion of forskolin. After 1 h, 2 h and 4 h
the animals were processed for cNMP extraction and analysis.
Extraction of cNMPs in C. elegans
Per sample 500–1000 synchronized 72 h old adult hermaphro-
dites were washed with 1 ml M9 buffer into a 1.5 ml safe-lock
Eppendorf tube. The animals were washed six times with 1 ml M9
buffer on ice in order to remove residual E. coli OP50. After the last
washing step the worms were incubated in M9 buffer for 20 min to
allow for digestion of the remaining bacteria in their gut followed
by a last washing step with 1 ml M9 buffer. The supernatant was
carefully removed and 300 ml of ice-cold extraction medium
(acetonitrile/methanol/water, 2/2/1 v/v/v) with 25 ng/ml teno-
fovir (TNF) as internal standard was added. Immediately, the
sample was frozen in liquid nitrogen for 30 s in order to stop
cNMP metabolism in the animals, followed by 60 s of incubation
in a 37uC water bath. This freeze-thaw cycle was repeated 6 times.
Subsequently, the sample was heated to 98uC for 20 min, cooled
down on ice and centrifuged at 20,0006g, and 4uC for 10 min.
The supernatant fluid was transferred into a new 2 ml Eppendorf
tube. The pellet of dead animals was extracted two more times
with 400 ml extraction medium for 15 min on ice and the
supernatants were combined. The fluid was evaporated under a
gentle nitrogen stream at 40uC. The residue was dissolved in water
and analyzed. For determination of the protein content, the cell
pellet was completely dried and resolved in 0.1 M NaOH at 95uC
for 10 min. One hundred ml of the solution was used in a Bradford
protein assay. For cNMP assessments of animals exposed to H2O2,
per sample 500–1000 synchronized 72 h old adult hermaphrodites
were washed with 1 ml M9 buffer into a 1.5 ml safe-lock
Eppendorf tube. When the animals were settled, the M9 buffer
was carefully removed and 200 ml of 10 mM H2O2 solution
added. The worms were incubated at 22uC for indicated time
points: 15 min, 30 min, 60 min, 90 min and 120 min. After the
incubation time the H2O2 solution was removed and the animals
washed with M9 buffer. Subsequently, the samples were treated as
above.
Quantitation of cNMPs by HPLC-MS/MS
The analysis of cNMP concentrations was performed via HPLC-
MS/MS. HPLC separation was performed on an Agilent 1100
series (Waldbronn, Germany) equipped with a binary pump
system. A Zorbax Eclipse XDB-C18 column (5064.6 mm, 1.8 mm
particle size, Agilent Technologies, CA, USA) was used as
stationary phase for analyte separation. The binary pump system
supplied two eluents for chromatographic analysis, eluent A (3/97
(v/v) methanol/H2O +50 mM NH4Oac +0.1% (v/v) acetic acid)
and eluent B (97/3 (v/v) methanol/H2O +50 mM NH4Oac
+0.1% (v/v) acetic acid). Parameters of the flow rates are
documented in Table 1. Analyte detection was conducted on the
sensitive Qtrap 5500 triple quadrupole mass spectrometer
(ABSCIEX, Foster City, CA, USA) using selected reaction
monitoring (SRM) analysis in positive ionization mode. Nitrogen
was used as collision gas for this purpose. The parameters of the
HPLC-MS/MS fragmentation and retention times are specified in
Table 2. The mass spectrometer parameters were as follows: ion
source voltage of 5,500 V; ion source temperature of 600uC;
curtain gas of 30 psi and collision gas of 9 psi. cNMP concentra-
tion in samples was quantified using the calibration curve obtained
by analysis of known amounts of pure cNMPs. Chromatographic
data was collected and analyzed using Analyst 1.5.1. TF software.
Validation of cNMP Quantitation by HPLC-MS/MS
A control set of cNMP samples (cAMP, cCMP, cGMP and
cUMP) was prepared in order to validate the cNMP quantitation.
One control set was prepared on five different days, of which five
technical replicates were measured. The mean of the daily
concentrations was taken resulting in the calculation of the mean
of five days which is presented in Table 3 (interday precision). The
intraday precision was calculated by measuring one set of controls
per day with five technical replicates. The mean is depicted in
Table 3. Additionally, the operator precision was determined. For
this purpose, on one day, five control sets were prepared and
measured one time. The mean is specified in Table 3. This
validation resulted in a linear range of 0.04–160 pmol/sample for
cAMP and 0.07–250 pmol/sample cCMP, cGMP and cUMP
(table 4). The lower limits of quantitation (LLOQ, accuracy,20%)
and the limits of detection (LOD, signal-to-noise.5) are depicted
in Table 4 for each cyclic nucleotide.
RNA Isolation
For RNA isolation of C. elegans, 500–1000 animals were pelleted
in a 1.5 ml safe-seal Eppendorf tube and washed 6 times with M9
buffer. The buffer was completely removed and the animals were
frozen immediately in liquid nitrogen. Subsequently, room-
temperature RA1/b-mercaptoethanol solution (350 ml/3.5 ml) of
the Nucleo Spin II-RNA Kit (Macherey & Nagel, Düren,
Germany) was added to the pellet and frozen down at 280uC
until use. The RNA extraction was performed with the Nucleo
Spin II-RNA Kit (Macherey & Nagel, Düren, Germany),
following the manufacturer’s instructions. The RNA concentra-
tions were determined by NanoDrop (Thermo Scientific, Wil-
mington, DE, USA). Total RNA (1 mg per sample) was taken for
first strand cDNA synthesis with MLVRT (Life Technologies,
Darmstadt, Germany). cDNA content was assessed by NanoDrop
(Thermo Scientific, Wilmington, DE, USA).
Table 1. Parameters of flow rates and gradients.
Total time Flow rate A [%] B [%]
0 min 0.4 ml/min 100 0
5 min 0.4 ml/min 50 50
5.1 min 0.4 ml/min 100 0
8 min 0.4 ml/min 100 0
doi:10.1371/journal.pone.0072569.t001
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Quantitative RT-PCR
A quantitative RT-PCR using Taqman probes was performed
in order to quantify the expression of distinct genes. First, RNA
isolation was performed followed by a reverse transcriptase
reaction. In order to conduct the PCR 2 ml of cDNA were
pipetted into the well of a 96-well plate and the following Taqman
probes were added: Ce02425242_m1 (pde-1), Ce02450556_m1
(pde-2), Ce02421830_m1 (pde-3), Ce02421841_m1 (pde-4),
Ce2417438_g1 (pde-5), Ce02413958_m1 (pde-6),
Ce2481960_m1 (daf-11), Ce02407231_m1 (pkg-1). RT-PCR
reactions were heat-started with 10 min at 95uC followed by 40
amplification cycles of 15 s at 95uC and 60 s at 60uC using
TaqMan Universal Master Mix (Life Technologies) and a Step
One Plus thermocycler (Applied Biosystems, Darmstadt, Ger-
many). The data were quantified using the comparative Ct (DDCt)
method, taken into account the different amplification efficiencies
for the different genes in the formula of DCt [25]. Data were
normalized to the geometric mean of two housekeeping genes. As
reference genes pmp-3 (putative ABC transporter) and Y45F10D.4
(putative iron-sulfur cluster enzyme) were used according to
[26,27], whose expression levels were stable during the assays.
Statistics
Data are presented as means 6 SEM or SD and are based on
3–12 independent experiments. GraphPad Prism software version
5.01 (San Diego, CA, USA) was used for calculation of means,
SEM and SD. Lifespan analysis was analyzed via the Meier-
Kaplan survival estimator and survival distributions were com-
pared by Log-rank test (Mantel-Cox test). P-values were calculated
by means of ANOVA Bonferroni’s multiple comparison test
with ***: p-value#0.001, **: p-value#0.01, and *: p-value#0.05.
P-values#0.05 were considered significant.
Results
An HPLC-MS/MS Assay for cAMP and cGMP in C. elegans
Wild-type animals were synchronized by bleaching and 72 h old
adult hermaphrodites were freeze-cracked to break their cuticle in
order to prepare the extracts. As proof-of-principle for these
applications in C. elegans, we first quantified cAMP and cGMP
levels in wild-type and mutant C. elegans strains. We compared the
cNMP levels in wild-type adults (N2), pde-4(ce268) II, a semi-
dominant, loss of function mutant, and a pde-1(nj57) pde-5(nj49) I;
pde-3(nj59) II; pde-2(tm3098) III quadruple loss of function mutant
(pde-1,2,3,5). PDE-4 is suggested to be a cAMP-degrading
phosphodiesterase in C. elegans and PDE-1 and PDE-5 are
postulated to degrade cNMPs, with a preference for cGMP [28].
Compared to wild-type animals, the pde-4 mutants showed
significantly higher concentrations of cAMP, a 2-fold increase, but
the cGMP level remained similar to wild-type levels (Figure 1 A,
B). In contrast, no change in cAMP levels were observed in the pde-
1,2,3,5 quadruple mutant compared to wild-type, while the
animals displayed a strong increase in cGMP concentration
(Figure 1 C, D). From these results we can infer that these two
mutants indeed are defective in degradation of cAMP or cGMP,
respectively, and that the differences in overall cNMP concentra-
tions in whole animals can be measured. The cAMP concentra-
tions of an adenylyl cyclase gain-of-function mutant (acy-1-gf) were
not significantly changed in comparison to wild-type animals
(Figure S1). We further tested our ability to quantify cAMP and
cGMP in the nematode by analyzing forskolin-treated animals.
Wild-type animals were incubated in a mixture of E. coli OP50
Table 2. Detection and quantitation parameters of the
quantification of cNMPs and IS TNF by HPLC-MS/MS.
cAMP cCMP cGMP cUMP tenofovir
[M+H]+ [m/z] 330.0 306.0 346.0 307.0 288.0
Quantifier [m/z] 135.9 112.0 151.9 96.9 176.0
Qualifier [m/z] 312.0 95.1 135.0 112.9 270.0
Ratio quantifier/
qualifier
1:5.2 1:4.0 1:2.5 1:1.9 1:2.2
Retention time 6.0 4.0 5.5 5.0 5.8
[M+H]+: protonated molecule mass, [m/z]: mass per charge, IS: internal
standard, TNF: tenofovir, HPLC-MS/MS: high performance liquid
chromatography coupled tandem mass spectrometry.
doi:10.1371/journal.pone.0072569.t002
Table 3. Validation of cNMP HPLC-MS/MS methodology.
cAMP cCMP cGMP cUMP
[pmol/sample] CV [%] [pmol/sample] CV [%] [pmol/sample] CV [%] [pmol/sample] CV [%]
Interday precision
QC low 0.10560.004 4.1 0.15460.01 8.4 0.17860.01 6.3 1.5960.05 3.1
QC medium 3.1360.14 4.5 5.1760.16 3.2 4.9860.18 3.6 19.1660.84 4.4
QC high 98.761.87 1.9 199.866.1 3.1 20466.1 3.0 216.162.17 1.0
Intraday precision
QC low 0.10460.01 8.6 0.15360.01 4.1 0.16760.01 6.9 1.5560.051 3.3
QC medium 2.9560.06 1.9 4.9260.07 1.5 4.7860.13 2.8 18.0862.58 2.6
QC high 97.462.35 2.41 202.469.23 4.6 206.4616.5 8.0 21567.6 3.5
Operator precision
QC low 0.09460.007 7.8 0.15360.01 5.0 0.17560.01 1.8 1.2860.041 3.3
QC medium 3.1260.18 5.8 5.160.39 7.6 4.8660.26 6.5 18.261.3 7.4
QC high 98.763.7 3.8 191.265.5 2.9 206.667.9 4.6 177.268.2 4.7
CV: coefficient of variation, HPLC-MS/MS: high performance liquid chromatography coupled tandem mass spectrometry, QC: quality control.
doi:10.1371/journal.pone.0072569.t003
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food and forskolin, a direct activator of adenylyl cyclases [19], with
a final concentration of 50 mM for 1 h, 2 h or 4 h. Only after 2 h,
a 3.5-fold increase of cAMP was detected whereas the cGMP
concentration was not affected by the addition of forskolin
(Figure 2). Forskolin needed to be ingested by the animals which
could explain the increase of cAMP not until 2 h. Rapid metabolic
inactivation of forskolin by the animals may explain the only
transient cAMP increase, i.e. after 4 h, the forskolin effect was only
minimal. The forskolin results support the findings in Figure 1 and
help to validate our methodology to detect and measure cAMP
and cGMP in C. elegans in addition to the validation methodology
described in Materials in Methods (Table 3). We could define a
linear range of 0.04–160 pmol/sample for cAMP and 0.07–
250 pmol/sample for cCMP, cGMP and cUMP (Table 4). The
lower limit of detection was found to be 0.02 pmol/sample for
cAMP, 0.013 pmol/sample for cCMP, 0.03 pmol/sample for
cGMP and 0.16 pmol/sample for cUMP (Table 4). Cyclic
pyrimidine nucleotides such as cCMP or cUMP could not be
detected in C. elegans (data not shown).
HPLC-MS/MS Quantitation of cAMP and cGMP in cGMP
Signaling Mutants
We next used our HPLC-MS/MS analysis system to measure
cGMP concentrations in C. elegans mutants with altered levels of
tolerance for oxidative (H2O2 -induced) stress. We further
investigated the role of the guanylyl cyclase daf-11 and egl-4/pkg-
1, a gene encoding the cGMP-dependent protein kinase, in H2O2
-induced stress responses. Basal levels of cAMP and cGMP were
determined in adult animals reared under standard C. elegans
culture conditions. No significant change in cAMP concentrations
was observed in any of the mutant strains compared to wild-type
(Figure 3 B). Since the mutated genes affect the cGMP signaling
pathway, this result for cAMP was expected. Interestingly, cGMP
concentrations in the daf-11 mutant also did not significantly differ
from the levels observed in wild-type; however, previous data led
us to expect a decrease in cGMP in daf-11 mutants (Figure 3 A)
[16]. The pde-1,2,3,5 loss of function mutant, of which PDE-1, 3
and 5 are suggested to degrade cGMP, had a 4-fold higher
concentration of cGMP than wild-type animals, confirming the
data of Figure 1. Surprisingly, the egl-4/pkg-1 mutant, having a
mutation that causes complete deletion of the protein kinase G,
showed even higher basal cGMP concentrations than the pde-
1,2,3,5 -quadruple mutant. The quadruple mutant harbored a 3.4-
fold increase in cGMP compared to wild-type levels (Figure 3 A).
In summary, the descending order of basal cGMP levels in all
strains was egl-4/pkg-1..pde-1,2,3,5.. daf-11 = wild-type.
Interestingly, both mutants that showed the highest cGMP
increase under H2O2 conditions also occurred to have the most
severe phenotypes in lifespan decrease (see below, Figure 4, Table
S2).
Stress Tolerance Assays and cAMP and cGMP
Quantitation in cGMP Signaling Mutants
Since daf-11 and cGMP levels have been implicated in longevity
and oxidative stress resistance, we analyzed the cGMP signaling
mutants in the context of stress. Under 10 mM H2O2 conditions
all the mutants displayed differences in tolerance to oxidative stress
in comparison to wild-type animals reared under normal growth
conditions (compare Figure 4 and Figure S2). The egl-4/pkg-1
mutant strain showed the least tolerance to oxidative stress, as
animals quickly died at this concentration of H2O2. After 15 min,
60% of the egl-4/pkg-1 animals were already dead, leading to a
median survival of only 15 min compared to 90 min of wild-type
C. elegans (Figure 4). The pde-1,2,3,5 quadruple mutant strain had
the same median survival as wild-type, 90 min, but after 60 min
almost 50% of the pde-1,2,3,5 mutant animals were dead in
comparison to 17% for wild-type. While the wild-type animals
lived 180 min, the longest lifespan of pde-1,2,3,5 quadruple
mutants was only 120 min (Figure 4). Since the daf-11 mutant
strain had already been reported to have an increased tolerance
for paraquat [16], an oxidative agent and one of the most widely
used herbicides in the world, we also examined the influence of the
stronger oxidative agent H2O2 on daf-11 mutants. The daf-11
mutant animals displayed a significant increase in lifespan in
comparison to wild-type animals when exposed to H2O2. The
mean survival of the daf-11 mutants was 270 min, in contrast to
90 min for the wild-type strain (Figure 4). The oxidative stress
resistance of the strains was as follows: daf-11.. wild-type .pde-
1,2,3,5.. egl-4/pkg-1 (Table S2).
In order to examine the cAMP and cGMP concentrations in
animals exposed to H2O2, the animals were synchronized,
grown to adults and incubated with a final concentration of
10 mM H2O2. After incubation for 15, 30, 60, 90 and 120 min,
the animals were processed for HPLC-MS/MS analysis. The
wild-type strain showed a slow increase in cGMP that peaked
after 90 min (Figure 5 A). Under the H2O2 conditions, the
cGMP concentration of the pkg-1 mutant strain increased in the
first 15 min which was the earliest response of all strains tested
and cGMP remained on a 3-fold higher level than the
untreated control for the duration of the experiment (Figure 5
B). The cGMP level of the pde-1,2,3,5-quadruple mutant
increased continuously throughout the 120 min duration of
the experiment, and the strain accumulated the highest level of
cGMP of all strains studied (Figure 5 C), in terms of the fold-
change as well as the absolute amount (Table 5). Remarkably,
daf-11 mutants exposed to H2O2 did not display a significant
change in cGMP concentration (Figure 5D) leading to the
assumption that daf-11 may be involved in mediating the H2O2-
induced cGMP increase. However, while cGMP was regulated
in different patterns in all mutant and wild-type strains
(Figure 5), the cAMP levels in all strains remained unchanged.
Absolute cGMP values in (pmol/mg protein) of all strains are
listed in Table 5. The descending order of the cGMP level in
Table 4. Linear range, LLOQ and LOD of cNMP methodology.
cAMP [pmol/sample] cCMP [pmol/sample] cGMP [pmol/sample] cUMP [pmol/sample]
Linear Range 0.04–160 0.07–250 0.07–250 0.4–250
LLOQ 0.04 0.07 0.07 0.4
LOD 0.02 0.013 0.03 0.16
LLOQ: lower limit of quantitation, accuracy,20%, LOD: limit of detection, signal-to-noise.5.
doi:10.1371/journal.pone.0072569.t004
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the presence of H2O2 of all strains used in the assay is pde-
1,2,3,5. egl-4/pkg-1.. wild-type.daf-11 (Table 5).
qRT-PCR Analysis of cGMP Signaling Mutants
Biosynthesis and degradation of cNMPs occurs in the context of
a wide network of interconnected cyclases and phosphodiesterases
is subject to allosteric influences and feedback regulation. We
considered that feedback regulation might also include regulation
at the transcriptional or mRNA stability level. We therefore
analyzed the relative mRNA abundance of the pde gene class as
well as mRNA levels of egl-4/pkg-1 and daf-11 in the cGMP
signaling mutants studied above. Wild-type, daf-11, pkg-1 and pde-
1,2,3,5 adult animals were harvested and processed for RNA
preparation. The levels of daf-11, pkg-1, pde-1, pde-2, pde-3, pde-4,
pde-5 and pde-6 gene expression were then quantified by qRT-PCR
for each of the strains. Although the reported mutation of the daf-
11 strain leading to an entire deletion of the cyclase domain of daf-
11 on the protein level, mRNA levels of daf-11 were up-regulated
(about 3.5-fold) [29]. Interestingly, the gene expression levels for
pde-1 and pde-5, encoding enzymes postulated to degrade cGMP
[16,18], were also elevated in daf-11 mutants (2.4-fold and 3.6-
fold, respectively) (Figure 6 A). The egl-4/pkg-1 mutant, harboring
a nonsense mutation, showed a reduction of egl-4/pkg-1 on the
mRNA level (0.47-fold), and a significant elevation of daf-11 gene
expression (11.6-fold), and an increase in pde-1 and pde-5 mRNA
expression as well (Figure 6 B). The mRNA accumulation profiles
for daf-11 and egl-4/pkg-1 mutants are remarkably similar
(Figure 6). By contrast, quantitation of the mRNA levels of the
pde-1,2,3,5-quadruple mutant revealed that daf-11 gene expression
was strongly reduced (0.21-fold) in the pde-1,2,3,5-quadruple
mutant (Figure 6 C). In all mutants tested, the regulation of the
pde-4 gene, which is a phosphodiesterase with a predicted
preference for cAMP degradation, was not significantly affected;
nor were effects noted for the expression of pde-2 or pde-6, whose
cNMP specificities have not been described yet (Figure 6, Table
S3).
Figure 1. cAMP and cGMP concentrations in wild-type vs. pde-4 (A, B) and wild-type vs. pde-1,2,3,5 (C, D). Animals were grown on NGM
plates at 22uC and harvested after they reached adulthood. N2: wild-type; pde-4 mutant: cAMP degrading PDE; pde-1,2,3,5 mutant: mainly cGMP
degrading PDEs. A, C display basal cAMP and B,D basal cGMP concentrations. Values represent means 6 SEM of at least three independent
experiments. P-values were calculated by means of one-way ANOVA with Bonferroni’s multiple comparison test with *: p-value#0.05, ***: p-
value#0.001, n.s.: not significant.
doi:10.1371/journal.pone.0072569.g001
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Discussion
cAMP and cGMP in vivo Analysis of C. elegans via HPLC-
MS/MS
Previous studies using C. elegans phosphodiesterase and adenylyl
or guanylyl cyclase mutants postulated decreased or enhanced
levels of cAMP or cGMP without biochemically analyzing the
actual cAMP or cGMP content of the animals. The assumptions of
cNMP levels were based on the nature of the enzyme activity that
was defective in the corresponding mutant or by exposing animals
to high concentrations of exogenous cNMPs [16,18,19]. These
assumptions may be incorrect, as the pathways that lead to
production and degradation of cAMP and cGMP are intercon-
nected and extensively cross-regulated. A defect in one element of
this network could lead to unexpected consequences with respect
to the balance of cNMPs in the cell.
We developed a HPLC-MS/MS methodology combined with a
particular preparation of C. elegans that is suitable for the specific
and sensitive simultaneous detection of cAMP and cGMP in the
nematode. For validating the HPLC-MS/MS methodology for C.
elegans oxidative stress assays, we examined phosphodiesterase
mutants, we assayed animals defective in particular adenylyl or
guanylyl cyclases, and we used forskolin to activate adenylyl
cyclases in C. elegans. Indeed, for the first time, we report definitive
data that will allow for direct comparisons of cNMP levels in whole
animals. In our initial proof-of-principal experiments, we observed
higher concentrations of cAMP in pde-4 loss-of-function mutants
in comparison to wild-type; whereas cGMP levels were not altered.
Additionally, a mutant containing loss of function mutations in the
four phosphodiesterase genes pde-1, pde-2, pde-3 and pde-5 showed a
significant elevation in cGMP levels (PDE-1 and PDE-5 were
postulated to degrade cGMP [16]) (Figure 1). By analyzing the
influence of forskolin, a direct activator of adenylyl cyclases, we
observed an enhanced accumulation of cAMP in wild-type C.
elegans. These initial results have allowed us to validate our HPLC-
MS/MS methodology in the C. elegans system for direct
comparisons between different cNMP levels.
Our data confirmed previous assumptions that cAMP levels are
upregulated in pde-4 mutants (Figure 1), which are defective for a
phosphodiesterase postulated to degrade cAMP. Both pde-4 loss –
of-function and acy-1(gf) gain-of-function mutants display in-
creased axon-regrowth behavior, and both strains are predicted
to harbor elevated levels of cAMP [19]. By contrast, we detected
no increase of cAMP in the same acy-1(gf) strain (Figure S1). These
unexpectedly contradictory results argue for a more complex role
for cNMPs in this interesting biological process. Similarly, our data
also support other assumptions that cGMP levels are increased in a
pde-1,2,3,5 quadruple mutant that displays enhanced photocurrent
[18] (Figure 1). With our new MS technology experiments
designed to uncover additional roles for cNMPs in axon-
regeneration and phototransduction can be performed with
confidence. We have used similar methodologies in analyses of
cNMP levels in mammalian cell lines, studies which allowed for
the definitive demonstration of the presence of the pyrimidine
nucleotides cCMP and cUMP [30]. cCMP or cUMP could not be
detected in C. elegans, a finding which not only highlights the
specificity of our technology, but also points to an evolutionary
and species-specific pattern of cNMP metabolism.
Analysis of cGMP Signaling Mutants and their Roles in
the H2O2 Stress Response
Correlation of cGMP concentrations and lifespan. C.
elegans is a useful organism for aging and oxidative stress research
[31,32,33,34]. As for mammals, restricted caloric up-take or
moderate oxidative stress can extend the lifespan of C. elegans. By
contrast, high levels of oxidative stress provoke cell death via
protein, lipid or DNA damage in both mammals and C. elegans
[35,36,37]. Long-lived mutants of C. elegans, such as daf-2, age-1,
and sir-2.1, express higher levels of the detoxifying enzymes
catalase and superoxide dismutase, allowing for increased oxida-
tive stress resistance, a phenotype that is correlated with lifespan
extension [16,32,33,38,39]. Mutants, lacking DAF-11, a receptor-
bound guanylyl cyclase, also live about 30% longer than wild-type
animals and are more resistant to paraquat, an oxidative agent
used as herbicide [16]. From these and other data, one might
hypothesize that low cGMP levels provoke lifespan extension and
mediate resistance to oxidative stress. Since we are now able to
quantify cAMP and cGMP in C. elegans via HPLC-MS/MS, we
utilized this new methodology to test this hypothesis by directly
Figure 2. Effect of forskolin (FSK) on cAMP (A) and cGMP (B)
concentrations in C. elegans. 3-day-old, adult animals were
incubated with 50 mM FSK for the indicated times. After 1 h, 2 h or
4 h, the animals were washed with M9 buffer and processed for HPLC-
MS/MS quantitation. Wild-type 0 h represents the untreated control.
Values represent means 6 SEM of three independent experiments in
pmol/mg protein. Please note the different y-axes of panels A and B. P-
values were calculated by means of one-way ANOVA with Bonferroni’s
multiple comparison test with **: p-value#0.005. The cGMP values are
not significant according to the analysis by one-way ANOVA with
Bonferroni’s multiple comparison test, the DMSO values decreased, but
the cGMP values almost remained on untreated wild-type level (B).
doi:10.1371/journal.pone.0072569.g002
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measuring cNMP levels in daf-11 and related mutants after
exposure to 10 mM H2O2.
In order to reveal correlations between cNMP levels and stress
response pathways, we analyzed loss-of-function C. elegans mutants
of the cGMP metabolic pathway. In both wild-type and the
quadruple phosphodiesterase pde-1,2,3,5 mutant, the levels of
cGMP increased progressively in response to the time of exposure
to H2O2, with the highest levels of cGMP accumulating in the
quadruple mutant. The pde-1,2,3,5 mutants also have higher than
normal levels of cGMP when untreated, while daf-11 mutants do
not (Figure 3). In contrast, the pkg-1 strain had the earliest
strongest cGMP increase, already after 15 min H2O2 incubation.
These two described mutant strains also displayed the greatest
sensitivity to oxidative stress (Figures 4 and 5). Surprisingly, basal
cGMP levels in guanylyl cylclase daf-11 mutants were unexpect-
edly unchanged in comparison to wild-type levels (Figure 5). Thus,
while the pde-1,2,3,5 and pkg-1 data support the hypothesis that
cGMP levels are inversely correlated with oxidative stress
resistance, the daf-11 data do not. Remarkably, cAMP concen-
trations were not affected by oxidative stress in any of the strains
we tested, which points to a particular role for cGMP in oxidative
stress mechanisms of C. elegans (Figure 5).
Strikingly, the cGMP levels of the untreated egl-4/pkg-1 mutants
were even higher than those of the pde-1,2,3,5 mutant (Figure 5).
Egl-4/pkg-1 is one of two closely related cGMP-dependent protein
kinase genes in C. elegans. The increased level of cGMP in egl-4/
pkg-1 mutants, coupled with the cell’s inability to transduce signals
through PKG-1, may provide indications of a compensatory feed-
back mechanism in the cGMP signaling pathway. Such compen-
satory mechanisms have been reported for superoxide dismutase
mutations in C. elegans. For example, in sod-2 deletion mutants, sod-
1, sod-3 and sod-4 mRNA levels were significantly elevated [34].
Under normal growth conditions, we did not observe an
extended lifespan for pkg-1 or daf-11 single mutants or the pde-
1,2,3,5 quadruple mutant (Figure S2). These findings are contrary
to lifespan data for pkg-1 and daf-11 mutants published by Hahm
et al. 2009 and Hirose et al. 2003, even though our experimental
approach to measuring lifespan was similar to that of Hahm et al.,
in that we utilized FUDR to prevent the development of progeny.
However, we utilized FUDR at 0.05 mg/ml while Hahm et al.
used a higher concentration (0.1 mg/ml). Differences in lifespan
may also be attributable to the growth temperature; our strains
were reared at 22uC, while the Hahm experiments were
performed at 20uC. Similarly the lifespan measurements per-
formed for egl-4/pkg-1 by Hirose et al. were performed at 20uC;
additionally, Hirose et al. assessed a different set of alleles. (The
pkg-1 mutants did display the typical enlarged body size phenotype
[40,41].).
Nevertheless, our observation, coupled with the fact that egl-4/
pkg-1 and the pde-1,2,3,5 quadruple mutants have high basal
cGMP contents (Figure 3), support a hypothesis that cGMP is not
the main player in enhanced or decreased lifespan under normal
growth conditions. Thus cGMP has differing influences on C.
Figure 3. HPLC-MS/MS analysis of basal cGMP (A) and cAMP (B) concentrations in C. elegans wild-type (N2) and cGMP signaling
mutants. Animals were grown to adult stage at 22uC on NGM plates and thus processed for HPLC-MS/MS cNMP quantitation. Data shown are the
means 6 SEM of seven independent experiments. P-values were calculated by means of one-way ANOVA with Bonferroni’s multiple comparison test
with ***: p-value#0.001, n.s.: not significant.
doi:10.1371/journal.pone.0072569.g003
Figure 4. C. elegans stress response assay at 226C in the
presence of 10 mM H2O2. Animals were synchronized by picking L1
larvae, grown on NGM plates. At the stage of adulthood the animals
were transferred to a 96-well plate containing 50 ml of 10 mM H2O2.
Values represent means 6 SEM of three independent experiments with
wild-type = 153 animals, pde-1,2,3,5 = 172 animals, pkg-1 = 102 animals
and daf-11 = 117 animals. Survival rates were calculated via the Meier-
Kaplan survival estimator and survival distributions were compared by
Log-rank test. P-values were calculated by Log-rank test with p-
values#0.05 considered as significant. P-values describe the significant
difference between wild-type and mutant strain survival during the
whole time course; p-values for all mutants (pde-1,2,3,5, pkg-1 and daf-
11): p,0.001. Dotted line: mean survival.
doi:10.1371/journal.pone.0072569.g004
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elegans’ lifespan depending on the environmental conditions. It
should be noted that our data obtained with worms cannot
necessarily be transferred to mammals.
The impact of background gene expression on the mutant
cGMP concentrations. As mentioned above, our data provide
evidence for compensatory feedback mechanisms that might
Figure 5. HPLC-MS/MS analysis of cGMP and cAMP of C. elegans mutants in the presence of H2O2. 72 h old, adult animals grown under
normal conditions, were exposed to 10 mM of H2O2 and incubated for defined times at 22uC. After incubation, the animals were washed, extracted
and and processed for HPLC-MS/MS quantification. A wild-type, B pkg-1 loss-of-function mutant, C quadruple pde loss-of-function mutant, D daf-11
(GC) loss-of-function mutant. Values normalized on the untreated control represent means 6 SEM of at least three independent experiments. Please
note the different scales of the y-axes of panel C. P-values were calculated by means of one-way ANOVA with Bonferroni’s multiple comparison test
with ***: p-value#0.001, n.s.: not significant. Please note in panel B and C: all times were tested for significant differences, but only the first incubation
time with significance is highlighted with asterics. For all the following incubation times, the cGMP concentrations were also significantly higher
(***:p-value#0.001) than the untreated control (0 min) determined by one-way ANOVA with Bonferroni’s multiple comparison test. -#-: cAMP, -&- :
cGMP.
doi:10.1371/journal.pone.0072569.g005
Table 5. cGMP concentration of all C. elegans strains in the presence of 10 mM H2O2.









mg protein) 6 SEM
0 min 4.7±0.86 8.3±0.93 34.7±2.5 17.3±2.2
15 min 4.460.49 10.761.7 135±12.8*** 29.363.0
30 min 5.360.58 9.960.90 120613.3*** 45.865.6**
60 min 7.461.01 11.761.2 97.464.9*** 79.268.8***
90 min 13.8±2.9*** 12.361.8 10866.2*** 104614.5***
120 min 6.261.0 13.661.6 98.764.6*** 155±12.0***
Animals were exposed to 10 mM H2O2 and incubated for defined times at 22uC. After defined incubation times animals were processed for HPLC-MS/MS analysis. Data
shown are means 6 SEM of three to four independent experiments in pmol/mg. P-values were calculated by means of one-way ANOVA with Bonferroni’s multiple
comparison test with ***: p-values ,0.001, significance was calculated of values compared to initial untreated values, n.s.: not significant.
doi:10.1371/journal.pone.0072569.t005
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explain the high basal cGMP levels we observed in egl-4/pkg-1
mutants (Figure 3). We investigated effects on mRNA accumula-
tion/transcription using qRT-PCR analysis of untreated mutants
defective in cGMP signaling or metabolic pathways. Indeed, in egl-
4/pkg-1 mutants, the daf-11 guanylyl cyclase mRNA was strongly
up-regulated (11.6-fold) in comparison to the level observed in
wild-type (Figure 6). This may lead to increased DAF-11 enzyme
production, and hence, the high basal cGMP levels (Figure 7). The
immediate and significant increase in cGMP levels observed in egl-
4/pkg-1 mutants in the presence of H2O2 (Figure 5) likely reflects
the overabundance of daf-11 mRNA, underlining the mediator
function of this guanylyl cyclase in the oxidative stress response.
The increase in daf-11 mRNA, and accompanying high cGMP
levels, detected in egl-4/pkg-1 mutants may also be responsible for
the up-regulation of pde-1 and pde-5 gene expression we observed
(Figure 7). Similar regulation of enzymes with opposite activities
with respect to cGMP metabolism would impart an ability of the
cell to maintain cGMP homeostasis; although, in egl-4/pkg-1
mutants, perfect homeostasis is not achieved (Figure 3). If this
model is correct, we can predict that increases in cGMP might
provoke an increase in pde-1 and pde-5 gene expression, and
decreases in cGMP would lead to upregulation of daf-11. Indeed,
we do observe a decrease in daf-11 mRNA levels in the pde-1,2,3,5
quadruple mutant (Figure 7). The pde-1,2,3,5 quadruple phos-
phodiesterase mutant has drastically elevated cGMP levels, and
not surprisingly, the expression level of the daf-11 guanylyl cyclase
is reduced. One might conclude that the reduced level of daf-
11 mRNA in this genetic background is not compromised, as the
cGMP product is more stable (Figure 3). These results confirm the
assumption that cNMP-degrading enzymes have a stronger impact
on intracellular cNMP levels in C. elegans than cNMP-generating
enzymes. Taken together, the collective data highlight the
potential for cross-talk between cGMP generating and degrading
enzymes in C. elegans (Figure 7).
Figure 6. mRNA expression of C. elegans pde genes, daf-
11 gene and pkg-1 gene on the basis of qRT-PCR analysis.
Animals were grown to adult stage (72 h) under normal conditions on
NGM plates at 22uC. 500–1000 worms were harvested and processed for
RNA extraction by freeze-crack and thus qRT-PCR analysis was
conducted in order to determine background gene regulation in the
cGMP-signaling pathway. Gene expression of A the daf-11, B the pkg-1
and C the pde-quadruple mutant background. Data shown are means
6 SEM of 3 to 8 independent experiments normalized on wild-type
level. Data have been normalized to the geometric mean of two
housekeeping genes Y45F10D.4 and pmp3 chosen. P-values were
calculated by means of one-way ANOVA with Bonferroni’s multiple
comparison test with ***: p-value#0.001; *: p-value#0.05. Please note
the different scales of panel A–C. Dashed lines depict 2-fold increase or
decrease in mRNA expression compared to wild-type.
doi:10.1371/journal.pone.0072569.g006
Figure 7. Crosstalk of daf-11/pkg-1/pde signaling in C. elegans
analyzed by qRT-PCR and HPLC-MS/MS analysis of cGMP.
Analysis of normal grown, adult cGMP signaling mutants revealed a
compensatory feedback response in egl-4/pkg-1 deletion mutants
towards daf-11, with enhanced daf-11 gene expression, resulting in
high cGMP concentrations and thus enhanced pde-1 and pde-5 gene
expression. Vice versa, pde- deletion mutants showed reduced pde-1
and pde-5 gene expression connected with decreased daf-11 expres-
sion levels pointing to a direct dependency of daf-11 and pde-1 and
pde-5 gene expression in both directions. Since egl-4/pkg-1 gene
expression was not affected in the daf-11 loss of function or the pde-
deletion background, there is only a feedback regulation based on egl-
4/pkg-1 gene expression. Red arrows stand either for down- (Q) or up-
regulation (q) of genes.
doi:10.1371/journal.pone.0072569.g007
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daf-11 mRNA is down-regulated in the pde-1,2,3,5 quadruple
mutant (Figure 6), yet the cGMP concentration increases in this
mutant in the presence of H2O2 (Figure 5). In contrast to
mammals, whose soluble guanylyl cyclases are activated by NO
[42,43], soluble guanylyl cyclases of C. elegans are activated by
oxygen (O2) (Figure S4) [44]. Therefore, it is possible that in the
presence of H2O2, detoxifying enzymes such as catalases, which
convert H2O2 into H2O and O2, might indirectly activate sGCs
and thus contribute to cGMP formation.
An ability to synthesize cGMP independently of DAF-11 can
explain why daf-11 mutants harbor normal cGMP levels (Figure 3).
This is remarkable when considering that daf-11 mutants also have
moderately increased levels of the phosphodiesterases pde-5 and
pde-1 (Figure 6). These data confirm the results of the egl-4/pkg-1
and pde-1,2,3,5 quadruple mutant indicating a strong correlation
between daf-11 and pde-5 gene expression (Figure 7). When daf-11
is upregulated pde-5 is elevated and when pde-5 is strongly down-
regulated, daf-11 gene expression is also reduced (Figure 6 C).
Limitations of our Study
Compartmentalization and short local increases in cNMPs
could be taken into consideration for explaining the effects of the
mutations in cNMP pathways. For example, aberrant compart-
mentalization in acy-1(gf) mutants may contribute to axon
regeneration and such subtle cellular displacements might be
below our ability to detect in our assays [45]. Also, our MS-based
method cannot analyze cNMP levels in specific cellular compart-
ments. Furthermore, our studies underline that only relying on
mutations is not sufficient for correct interpretation of results, since
the mutations do not necessarily correlate with the situation of
intracellular cNMP concentrations in vivo (Figure S1).
We identified the receptor-bound guanylyl cyclase DAF-11 as
the mediator of H2O2-induced cGMP increase in C. elegans and
found that the cGMP concentration inversely correlates with the
life expectancy of the nematode in the presence of H2O2 while
the cAMP pathway does not seem to be part of the oxidative
stress response. This was not only confirmed by HPLC-MS/MS
quantitation but also by qRT-PCR analysis, which revealed no
regulation of the pde-4 gene, encoding for a cAMP degrading
PDE, in any cGMP signaling mutant (Figure 6). Our data
provides evidence that DAF-11 might not be the only guanylyl
cyclase that generates cGMP in response to H2O2. It is likely
that soluble guanylyl cyclases are also involved in this process.
Our analysis of the gene expression profile in C. elegans
cGMP-signaling mutants via RT-PCR assays showed that it is
important to take into consideration that daf-11/pkg-1/pde
crosstalk occurs. In contrast to C. elegans, oxidative stress
studies with HEK293 cells overexpressing the DAF-11 ortholog
pGC-A [46], showed a simultaneous regulation of cAMP and
cGMP (Figure S3) indicating that cross-talk of cGMP and
cAMP occurs in mammalian cells upon H2O2 exposure. While
these results highlight the differences between the two systems,
C. elegans is a useful model organism for initial exploration
experiments in cNMP signaling upon oxidative stress, because
the reduced level of cross-talk and absence of NO responses
might allow for a more complete elucidation of novel cNMP
pathways [47,48].
The particular interpretation of the C. elegans cGMP regulation
under normal and oxidative stress conditions could only be
realized by profiling the levels of mRNAs of other components in
the cGMP signaling pathway in order to comprehend the impacts
of specific gene function and environmental stressors on the
biochemical results. Thus, it is important not only to analyze C.
elegans mutants by a biochemical or a genetic approach but by the
combination of both.
Future Perspectives
Due to the lack of intense immunochemistry in C. elegans in the
past, the field of protein biochemistry is just evolving providing
reliable antibodies in order to study the effects of H2O2 on the
protein level. Therefore, on the one hand future studies will focus
on elucidating the impact of oxidative stress on the protein level of
daf-11, egl-4/pkg-1 and pdes. On the other hand, the pharmaco-
logical manipulation of C. elegans using guanylyl cyclase activators/
inhibitors, PDE inhibitors or membrane permeable cNMP
analogs, with and without exposition to oxidative stress will
provide further information in how far the members of the cGMP-
signaling pathway are involved in the oxidative stress response.
Supporting Information
Figure S1 HPLC-MS/MS quantitation of cAMP (A) and
cGMP (B) of wild-type (N2) and acy-1 gain-of-function
animals. Nematodes were synchronized and grown under
normal conditions on NGM agar plates to adulthood at 22uC.
No significant difference in A cAMP and B cGMP concentrations
could be detected. Values represent means 6 SEM normalized on
wild-type cNMP concentrations, n.s.: not significant.
(TIF)
Figure S2 Lifespan analysis of C. elegans at 226C under
normal growth conditions. NGM plates were supplemented
with 0.05 mg/ml FUDR in order to inhibit progeny overgrowth.
Data shown are means 6 SEM of three independent experiments
with N2 = 267 animals, A pde-1,2,3,5 = 259 animals, B pkg-1 = 277
animals and C daf-11 = 281 animals. Survival rates were calculated
via the Meier-Kaplan survival estimator and survival distributions
were compared by logrank test. P-values were calculated by Log-
rank test with p-values#0.05 considered as significant. P-values
depicted in panels A–D describe the significant difference between
wild-type and mutant strain survival during the whole time course.
Dotted line: mean survival.
(TIF)
Figure S3 HPLC-MS/MS analysis of Hek293 WT vs.
Hek293 overexpressing pGC-A in the presence of H2O2.
Panels A, C, E, G display cGMP and panels B, D, F, H cAMP
levels normalized on the cNMP values of the untreated control.
Values represent means 6 SEM of three independent experi-
ments. P-values were calculated by means of ANOVA Bonferro-
ni’s multiple comparison test with ***: p-value#0.001, **: p-
value#0.01, *: p-value#0.05, n.s.: not significant. Please note the
different scale of the y-axes of panel A.
(TIF)
Figure S4 C. elegans soluble guanylyl cyclase dependent
cGMP signaling in ciliated neurons. Soluble guanylyl
cyclases (sGC) GCY-35 and GCY-36 of C. elegans are activated
by O2. Subsequently, GTP is converted to cGMP. cGMP effectors
are cGMP-gated channels (TAX-2 and TAX-4), PKG-1 (protein
kinase 1) and most likely PDE 1, 2 and 5 (cGMP degrading
phosphodiesterases). Activation of sGC results in avoidance of
hyperoxia, bordering and aggregation of the animals on a bacterial
lawn [46].
(TIF)
Figure S5 Concentration-response curve of wild-type C.
elegans incubated with H2O2. 72 h old adult animals were
incubated with increasing concentrations of H2O2:2.5 mM,
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5 mM, 7.5 mM, 10 mM and 15 mM. After 2 h, the living animals
were identified by tapping the nematodes with a plantinum wire-
pick. The animals were counted as alive when they responded to
the pick, otherwise they were counted as dead. With a
concentration of 15 mM, almost all animals were dead after 2 h
of incubation. Therefore, a final concentration of 10 mM H2O2
was chosen, in order to conduct a time-dependent H2O2 stress
assay.
(TIF)
Table S1 C. elegans cGMP signaling pathway mutants
used in this study.
(DOCX)
Table S2 C. elegans survival in the presence of 10 mM
H2O2 (up to 270 min).
(DOCX)
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